Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1959 1
1962 1
1985 2
1986 2
1989 1
1992 1
1994 4
1995 1
1997 6
1998 3
1999 2
2000 3
2001 2
2002 4
2003 5
2004 5
2005 8
2006 8
2007 1
2008 9
2009 3
2010 1
2011 1
2012 1
2013 1
2014 1
2015 1
2016 1
2018 2
2019 2
2020 3
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 3093966

85 results
Results by year
Filters applied: . Clear all
Page 1
Varicella: complications and costs.
Preblud SR. Preblud SR. Pediatrics. 1986 Oct;78(4 Pt 2):728-35. Pediatrics. 1986. PMID: 3093966 Review.
A benefit-cost analysis of a childhood varicella vaccination programme.
Preblud SR, Orenstein WA, Koplan JP, Bart KJ, Hinman AR. Preblud SR, et al. Postgrad Med J. 1985;61 Suppl 4:17-22. Postgrad Med J. 1985. PMID: 3939152
One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
Lopez AS, Guris D, Zimmerman L, Gladden L, Moore T, Haselow DT, Loparev VN, Schmid DS, Jumaan AO, Snow SL. Lopez AS, et al. Pediatrics. 2006 Jun;117(6):e1070-7. doi: 10.1542/peds.2005-2085. Pediatrics. 2006. PMID: 16740809
Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
Wutzler P, Neiss A, Banz K, Goertz A, Bisanz H. Wutzler P, et al. Med Microbiol Immunol. 2002 Oct;191(2):89-96. doi: 10.1007/s00430-002-0123-4. Epub 2002 Aug 29. Med Microbiol Immunol. 2002. PMID: 12410347
Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.
Jean-Jasmin LM, Lynette SP, Stefan M, Kai CS, Chew FT, Wah LB. Jean-Jasmin LM, et al. Southeast Asian J Trop Med Public Health. 2004 Sep;35(3):693-6. Southeast Asian J Trop Med Public Health. 2004. PMID: 15689089
Clinical and economic considerations of vaccination against varicella.
Strassels SA, Sullivan SD. Strassels SA, et al. Pharmacotherapy. 1997 Jan-Feb;17(1):133-9. Pharmacotherapy. 1997. PMID: 9017774 Review.
[Varicella disease and varicella vaccine. A literature review].
Frederiksen MS, Plesner AM, Stellfeld M. Frederiksen MS, et al. Ugeskr Laeger. 2003 Jun 2;165(23):2387-91. Ugeskr Laeger. 2003. PMID: 12840997 Review. Danish.
Cost-effectiveness of varicella vaccination programs: an update of the literature.
Rozenbaum MH, van Hoek AJ, Vegter S, Postma MJ. Rozenbaum MH, et al. Expert Rev Vaccines. 2008 Aug;7(6):753-82. doi: 10.1586/14760584.7.6.753. Expert Rev Vaccines. 2008. PMID: 18665775 Review.
Varicella prevention in the United States: a review of successes and challenges.
Marin M, Meissner HC, Seward JF. Marin M, et al. Pediatrics. 2008 Sep;122(3):e744-51. doi: 10.1542/peds.2008-0567. Pediatrics. 2008. PMID: 18762511 Review.
Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
[No authors listed] [No authors listed] Prescrire Int. 2005 Jun;14(77):85-91. Prescrire Int. 2005. PMID: 15977369
85 results
Jump to page
Feedback